Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Prinses Máxima Centrum

Hans Clevers takes on a new challenge at Roche

Prof. dr. Hans Clevers, previously Scientific Director of the Princess Máxima Center for pediatric oncology and currently Group Leader, will be appointed Head of Roche Pharma Research and Early Development (pRED) and a member of the company’s Corporate Executive Committee as of March 18, 2022. Clevers will remain actively involved in the research of the Máxima center as an advisor / visiting researcher.

Hans Clevers about the next step in his career: ‘After more than 40 years of working with fantastic colleagues in academic laboratories, my passion for science is unabated. In the coming years at Roche, I hope to use all the knowledge I have gained to contribute to the development of essential, accessible medicines.’

Alexander Eggermont, scientific director of the Princess Máxima Center for Pediatric Oncology: ‘Hans Clevers has played an important role in the establishment and construction of the largest pediatric cancer center in Europe. He was involved from the very beginning and laid the foundation for our scientific research activities. We thank him for all his efforts for the Princess Máxima Center, and are proud to announce that he will remain actively involved in the Máxima as an advisor/visiting researcher and wish him every success for the future.’

Hans Clevers was awarded his MSc in Biology, MD and PhD all at Utrecht University. He is currently a professor at Utrecht University and group leader at the Hubrecht Institute and the Princess Máxima Center for pediatric oncology. In addition, he serves on several scientific advisory boards, including that of the Francis Crick Institute, and is a co-founder of several companies. He is a member of the Royal Dutch Academy of Sciences, the National Academy of Science in the United States, the Academy of Science in France and The Royal Society in the United Kingdom. Hans Clevers has been on the Board of Directors at Roche since 2019.